We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care

    Background

    Aging population has led to an increased proportion of older adults and cognitively impaired. We designed a brief and flexible two-stage...

    Liang Cui, Zhen Zhang, ... Qi-Hao Guo in BMC Psychiatry
    Article Open access 25 May 2023
  2. Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes

    Introduction

    Guidelines recommend screening older people (> 60–65 years) with type 2 diabetes (T2D) for cognitive impairment, as it has implications...

    Anu Gupta, Alpesh Goyal, ... Yashdeep Gupta in Diabetes Therapy
    Article Open access 23 March 2024
  3. Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia

    The Cognitive Assessment Interview (CAI) is an interview-based scale measuring cognitive impairment and its impact on functioning in subjects with...

    Paola Bucci, Armida Mucci, ... Elisa Del Favero in European Archives of Psychiatry and Clinical Neuroscience
    Article Open access 28 June 2023
  4. Advancing Cognitive Health in Aging Populations by Leveraging Digital Assessment

    As the number of older adults is expected to rise, there exists a need for accessible tools that capture nuanced changes in cognition. Modern digital...

    Quentin Coppola, Marc Yangüez, ... Aaron Seitz in Journal of Health Service Psychology
    Article 01 February 2024
  5. Develo** a cognitive assessment toolkit for primary care: qualitative assessment of providers’ needs and perceptions of usability in clinical practice

    Background

    Burden of dementia is expected to substantially increase. Early dementia is underdiagnosed in primary care. Given the benefits of active...

    Monica Zigman Suchsland, Barak Gaster, ... Annette L. Fitzpatrick in BMC Health Services Research
    Article Open access 19 September 2023
  6. The Ethiopian Cognitive Assessment battery in Schizophrenia (ECAS): a validation study

    Cognitive impairment is common in people with schizophrenia (PWS). To detect the presence and its consequences, cognitive measures with sound...

    Yohannes Gebreegziabhere, Kassahun Habatmu, ... Atalay Alem in Schizophrenia
    Article Open access 06 April 2024
  7. Patient-Centered Approaches to Cognitive Assessment in Acute TBI

    Purpose of the Review

    The purpose of this article is to help clinicians understand how underlying pathophysiologies and medical comorbidities...

    Leslie W. Johnson, Carley Prenshaw, Amber Corbin in Current Neurology and Neuroscience Reports
    Article 27 January 2023
  8. Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments

    Background

    Progressive cognitive decline is an inevitable feature of Huntington’s disease (HD) but specific criteria and instruments are still...

    Andrea Horta-Barba, Saul Martinez-Horta, ... Jaime Kulisevsky in Journal of Neurology
    Article Open access 18 July 2023
  9. Rates of Undiagnosed Cognitive Impairment and Performance on the Montreal Cognitive Assessment Among Older Adults in Primary Care

    Background

    The number of adults in the USA with cognitive impairment is increasing; however, few studies report prevalence rates of undiagnosed...

    Alex D. Federman, Jacqueline H. Becker, ... Juan Wisnivesky in Journal of General Internal Medicine
    Article 22 February 2023
  10. Evidence supporting the use of a brief cognitive assessment in routine clinical assessment for psychosis

    Cognitive impairment is a core feature of psychosis. Full cognitive assessments are not often conducted in routine clinical practice as...

    M. Cowman, E. Lonergan, ... G. Donohoe in Schizophrenia
    Article Open access 17 December 2022
  11. Comprehensive assessment of fine motor movement and cognitive function among older adults in China: a cross-sectional study

    Background

    Fine motor skills are closely related to cognitive function. However, there is currently no comprehensive assessment of fine motor movement...

    Jie Zhang, Ye-**g Zhao, ... **g Li in BMC Geriatrics
    Article Open access 31 January 2024
  12. P300 in peripheral neuropathy: cognitive functions assessment and gender effect

    Background

    Patients with peripheral neuropathy (PN) have subtle central pathology that might contribute to cognitive impairment. P300 is a cognitive...

    Mohammad Mejahed, Amira M. Ibrahim, ... Takwa A. Gabr in Egyptian Rheumatology and Rehabilitation
    Article Open access 01 November 2023
  13. The assessment of the impact of antiepileptic drugs on cognitive functions via N-200/P-300 potentials and neuropsychological measures

    Objective

    The effects of antiseizure medications (ASMs) on cognitive functions have not been fully elucidated. The primary aim of this study was to...

    Javid Shafiyev, Ömer Karadaş in Neurological Sciences
    Article Open access 25 May 2024
  14. Associations between Participant Characteristics and Participant Feedback about an Unsupervised Online Cognitive Assessment in a Research Registry

    Background

    This study aims to understand whether and how participant characteristics (age, gender, education, ethnocultural identity) are related to...

    Miriam T. Ashford, J. Eichenbaum, ... R. L. Nosheny in The Journal of Prevention of Alzheimer's Disease
    Article Open access 19 April 2023
  15. Cognitive impairment according to Montreal Cognitive Assessment independently predicts the ability of chronic obstructive pulmonary disease patients to maintain proper inhaler technique

    Background

    Maintaining correct inhaler technique is crucial in the management of chronic obstructive pulmonary disease (COPD). We aimed to investigate...

    Chonnipha Iamthanaporn, Apiradee Wisitsartkul, Benjamas Chuaychoo in BMC Pulmonary Medicine
    Article Open access 26 April 2023
  16. Translation and validation of the audiovisual version of the Montreal cognitive assessment in older adults in Brazil

    Background

    The use of a reliable remote cognitive screening test for older adults is crucial for the diagnosis of cognitive impairment. This study...

    Cíntia Monteiro Carvalho, Karin Reuwsaat de Andrade, ... Rogerio Panizzutti in BMC Geriatrics
    Article Open access 03 January 2024
  17. Cognitive functioning in women with breast cancer: psychometric properties of the Arabic version of the Functional Assessment of Cancer Therapy-Cognitive Function Tool

    Background

    The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) evaluates perceived cognitive functioning and their impact on...

    Mariam Hassan, Zainab Barakat, ... Linda Abou-Abbas in Health and Quality of Life Outcomes
    Article Open access 28 January 2023
  18. Auditory cognitive assessment in post COVID-19 patients: a case control study

    Background

    There is increasing evidence suggesting that individuals with coronavirus disease 2019 (COVID-19) may experience symptoms that persist...

    Hoda Mahmoud Weheiba, Rasha Hamdi E. L. Kabarity, ... Abeer Mohamed Mohamed EL-Gendy in The Egyptian Journal of Otolaryngology
    Article Open access 09 January 2024
  19. Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease

    Background

    This study is aimed at assessing the clinimetric properties and feasibility of the Italian version of the Montreal Cognitive Assessment...

    Edoardo Nicolò Aiello, Federica Solca, ... Barbara Poletti in Neurological Sciences
    Article 28 September 2023
  20. Combining Mini-Mental State Examination and Montreal Cognitive Assessment for assessing the clinical efficacy of cholinesterase inhibitors in mild Alzheimer’s disease: a pilot study

    Current drugs for Alzheimer’s Disease (AD), such as cholinesterase inhibitors (ChEIs), exert only symptomatic activity. Different psychometric tools...

    Giovanna Furneri, Simone Varrasi, ... Roberto Monastero in Aging Clinical and Experimental Research
    Article Open access 17 April 2024
Did you find what you were looking for? Share feedback.